IH2 INHIBITION ENHANCES PROTEASOME INHIBITOR RESPONSIVENESS IN HEMATOLOGICAL MALIGNANCIES. (12th June 2019) - Piva, R.; Bergaggio, E.; Riganti, C.; Vitale, N.; Garaffo, G.; Mereu, E.; Bandini, C.; Pellegrino, E.; Pullano, V.; Labrador, M.; Bertoni, F.; Deaglio, S.; et al.